Kairos Share Price

Kairos Share Price

AMEX: KAPA | Micro Cap | Healthcare
$0.42
+$0.42 (--%) Last updated on 21 Nov, 2026 | 02:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Kairos Stock Performance

Open
$0.45
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.45 - $0.45
Year Range
$0.22 - $2.15
Volume
202
Average Traded
$0.45

Kairos Share Price Chart

Line chart of the Kairos price trend over the selected period. The price rose overall, ranging from 0.42 to 0.45, ending at 0.42.
$0.45$0.45
L
Show Current Price
H

Kairos Stock Fundamentals & Key Indicators

Market Cap
$7.74M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-164.93%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-44.53%

Kairos Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.37-$1.65-$1.39-$1.98
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-20.44%15.76%-42.45%

Kairos Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$2.60-$5.45
Net Profit MarginN/AN/A
Income ChangeN/A-109.62%

Kairos Balance Sheet

All figures in USD Million

Particulars202520242022
Non Current Assets1.151.60.86
Current Assets5.394.170.1
Total Assets6.545.770.97
Non Current Liabilities0.00.00.64
Current Liabilities0.20.992.41
Total Liabilities0.20.993.04
Shareholders' Equity6.344.78-2.08

Kairos Cash Flow

Annually
Particulars20252024
Operating (USD Million)-3.44-3.96
Investing (USD Billion)0.00.0
Financing (USD Million)6.665.13

Corporate Actions

Split
Ex-date: 01 Sep 2026

About Kairos

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.

Kairos Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.53
$0.45
-15.37%
Oct 2026
$1.55
$0.53
-68.63%
Sep 2026
$1.59
$1.68
+594.21%
Aug 2026
$0.30
$0.24
-22.68%
Jul 2026
$0.37
$0.31
-19.74%
Jun 2026
$0.50
$0.39
-22.16%
May 2026
$0.56
$0.50
-12.11%
Apr 2026
$0.55
$0.57
+1.60%
Mar 2026
$0.62
$0.56
-8.18%
Feb 2026
$0.68
$0.61
-10.15%
Jan 2026
$0.72
$0.68
-4.36%
Dec 2025
$0.79
$0.71
-5.07%

Kairos Share Price FAQs